Comparison of metformin and pioglitazone in achieving sustained virological response in chronic hepatitis C patients with insulin resistance: A quasi-experimental study.

Khan, Imran Mahfooz; Malik, Bilal Rafique; Randhawa, Fawad Ahmad; Butt, Nasir Farooq; Malik, Uzma; Hamid, Shahid

Khan, Imran Mahfooz; Malik, Bilal Rafique; Randhawa, Fawad Ahmad; Butt, Nasir Farooq; Malik, Uzma; Hamid, Shahid.

Afiliação

Khan IM; Department of Medicine, King Edward Medical University, Lahore.
Malik BR; Post-Graduate Trainee, East Medical Ward, Mayo Hospital, Lahore.
Randhawa FA; Department of Medicine/Endocrinology, King Edward Medical University, Lahore.
Butt NF; Department of Medicine, King Edward Medical University, Lahore.
Malik U; Department of Medicine, King Edward Medical University, Lahore.
Hamid S; Department of Medicine, King Edward Medical University, Lahore.

J Pak Med Assoc ; 67(12): 1848-1852, 2017 Dec.

Article em En | MEDLINE | ID: mdl-29256528

Assuntos

Hepatite C Crônica; Hipoglicemiantes/uso terapêutico; Resistência à Insulina/fisiologia; Metformina/uso terapêutico; Pioglitazona/uso terapêutico; Adulto; Antivirais/uso terapêutico; Glicemia; Feminino; Hepatite C Crônica/tratamento farmacológico; Hepatite C Crônica/fisiopatologia; Humanos; Interferons/uso terapêutico; Masculino; Pessoa de Meia-Idade; Resposta Viral Sustentada

Palavras-chave

Hepatitis C, Interferon, Insulin resistance, Metformin, Pioglitazone.

Buscar no Google

Imprimir

XML

PubMed Links

Base de dados: MEDLINE Assunto principal: Resistência à Insulina / Hepatite C Crônica / Pioglitazona / Hipoglicemiantes / Metformina Limite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: J Pak Med Assoc Ano de publicação: 2017 Tipo de documento: Article

Buscar no Google

Imprimir

XML

PubMed Links